Weiding Wu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 11
- Peptidase Inhibition and Analysis 3
-
- RNA modifications and cancer 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
-
- Immune Cell Function and Interaction 4
-
- Neuroendocrine Tumor Research Advances 3
- Journals
- Cell Death and Disease (3 papers)Acta Biochimica et Biophysica Sinica (3 papers)Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weiding Wu
37 papers receiving 662 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 226
- Oncology 248
- Molecular Biology 345
- Surgery 196
- Hepatology 35
Countries citing papers authored by Weiding Wu
This map shows the geographic impact of Weiding Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiding Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiding Wu more than expected).
Fields of papers citing papers by Weiding Wu
This network shows the impact of papers produced by Weiding Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiding Wu. The network helps show where Weiding Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiding Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 23 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 28 | |
| 10 | 2020 | 30 | |
| 11 | 2020 | 23 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 33 | |
| 14 | 2019 | 30 | |
| 15 | 2018 | 2 | |
| 16 | 2017 | 17 | |
| 17 | 2016 | 3 | |
| 18 | 2015 | 14 | |
| 19 | 2014 | 5 | |
| 20 | 2014 | 3 |
About Weiding Wu
Weiding Wu is a scholar working on Oncology, Cancer Research, Immunology, Hepatology and Gastroenterology, having authored 37 papers that have together received 670 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers), Immune Cell Function and Interaction (4 papers), RNA modifications and cancer (4 papers), Peptidase Inhibition and Analysis (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Cancer Research (226 citations), Oncology (248 citations), Molecular Biology (345 citations), Surgery (196 citations) and Hepatology (35 citations). Weiding Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhiming Hu, Long‐Yun Ye, Xianjun Yu, Kaizhou Jin, Cheng-Wu Zhang, Defei Hong, Boan Zheng, Xiqiang Liu, Xiaowu Xu and Zhenyuan Qian. Their work appears in journals such as Cell Death and Disease, Acta Biochimica et Biophysica Sinica, Medicine, International Journal of Molecular Sciences and Surgical Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.